title: Developments in diagnosing and treating otitis media.
abstract: Acute otitis media is commonly caused by pneumococcus and Hemophilus influenzae. Amoxicillin is recommended as the initial therapy when the causative agent has not been identified. If amoxicillin is ineffective, cefaclor is useful. Decongestants are of little proven value. Since most middle ear effusions resolve spontaneously in three to four months, surgical treatment is seldom indicated.
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D006311:Hearing Disorders / Q000209:etiology; D006801:Humans; D007223:Infant; D008403:Mass Screening; D008876:Middle Ear Ventilation; D010033:Otitis Media / Q000175:diagnosis / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy*; D010034:Otitis Media with Effusion / Q000150:complications / Q000628:therapy; D012008:Recurrence; D013296:Streptococcus pneumoniae / Q000276:immunology; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
chemical_list: D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole